Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 448

1.

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective.

Aapro M, Gascón P, Patel K, Rodgers GM, Fung S, Arantes LH Jr, Wish J.

Front Pharmacol. 2019 Jan 9;9:1498. doi: 10.3389/fphar.2018.01498. eCollection 2018. Review.

2.

Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV).

Baron-Hay S, Aapro M, Bernareggi A, Schwartzberg L.

Support Care Cancer. 2019 Jan 26. doi: 10.1007/s00520-019-4640-8. [Epub ahead of print]

PMID:
30685793
3.

Integration of oncology and palliative care: a Lancet Oncology Commission.

Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gómez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R, Rodin G, Sjøgren P, Stone P, Zimmermann C, Lundeby T.

Lancet Oncol. 2018 Nov;19(11):e588-e653. doi: 10.1016/S1470-2045(18)30415-7. Epub 2018 Oct 18. Review.

PMID:
30344075
4.

Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study.

Ludwig H, Gascón P, Bokemeyer C, Aapro M, Boccadoro M, Denhaerynck K, Krendyukov A, MacDonald K, Abraham I.

Support Care Cancer. 2018 Oct 20. doi: 10.1007/s00520-018-4513-6. [Epub ahead of print]

PMID:
30343410
5.

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines.

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv271. doi: 10.1093/annonc/mdy323. No abstract available.

PMID:
30285221
7.

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.

Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Diéras V, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen BV, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Xu B, Norton L, Winer EP.

Ann Oncol. 2018 Aug 1;29(8):1634-1657. doi: 10.1093/annonc/mdy192. No abstract available.

PMID:
30032243
8.

Is the Dexamethasone-Sparing Strategy Ready For Cisplatin? Too Early For an Answer.

Celio L, Bonizzoni E, Aapro M.

J Clin Oncol. 2018 Sep 10;36(26):2741-2742. doi: 10.1200/JCO.2018.78.8109. Epub 2018 May 25. No abstract available.

PMID:
29799771
9.

De vrais espoirs et de sérieuses préoccupations.

Peters S, Dietrich PY, Aapro M.

Rev Med Suisse. 2018 May 16;14(607):1011-1012. French. No abstract available.

PMID:
29767891
10.

Development and 10-year history of a biosimilar: the example of Binocrit®.

Aapro M, Krendyukov A, Höbel N, Seidl A, Gascón P.

Ther Adv Med Oncol. 2018 Apr 17;10:1758835918768419. doi: 10.1177/1758835918768419. eCollection 2018. Review.

11.

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-concluding thoughts.

Aapro M.

Support Care Cancer. 2018 Mar;26(Suppl 1):35-37. doi: 10.1007/s00520-018-4121-5. Epub 2018 Mar 19. No abstract available.

12.

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-introduction.

Aapro M.

Support Care Cancer. 2018 Mar;26(Suppl 1):3-4. doi: 10.1007/s00520-018-4147-8. Epub 2018 Mar 19. No abstract available.

13.

CINV: still troubling patients after all these years.

Aapro M.

Support Care Cancer. 2018 Mar;26(Suppl 1):5-9. doi: 10.1007/s00520-018-4131-3. Epub 2018 Mar 19.

14.

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-CME information.

Aapro M, Clemons M, Schwartzberg L, Warr D.

Support Care Cancer. 2018 Mar;26(Suppl 1):1-2. doi: 10.1007/s00520-018-4122-4. Epub 2018 Mar 19. No abstract available.

PMID:
29556807
15.

Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience Gained.

Aapro M, Krendyukov A, Schiestl M, Gascón P.

BioDrugs. 2018 Apr;32(2):137-138. doi: 10.1007/s40259-018-0268-3.

PMID:
29492906
16.

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines.

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J; ESMO Guidelines Committee.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv96-iv110. doi: 10.1093/annonc/mdx758. No abstract available.

17.

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.

Martin M, Campone M, Bondarenko I, Sakaeva D, Krishnamurthy S, Roman L, Lebedeva L, Vedovato JC, Aapro M.

Ann Oncol. 2018 May 1;29(5):1195-1202. doi: 10.1093/annonc/mdy063.

PMID:
29447329
18.

Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years' Experience Gained.

Aapro M, Krendyukov A, Schiestl M, Gascón P.

BioDrugs. 2018 Apr;32(2):129-135. doi: 10.1007/s40259-018-0262-9. Review. Erratum in: BioDrugs. 2018 Feb 28;:.

19.

European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.

Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotté F, Strasser F, Young A, Bruera E, Herrstedt J, Keefe D, Laird B, Walsh D, Douillard JY, Cervantes A.

Ann Oncol. 2018 Jan 1;29(1):36-43. doi: 10.1093/annonc/mdx757.

PMID:
29253069
20.

Continuity and diversity.

Aapro M.

Crit Rev Oncol Hematol. 2018 Jan;121:A2. doi: 10.1016/j.critrevonc.2017.12.001. Epub 2017 Dec 7. No abstract available.

PMID:
29242024

Supplemental Content

Loading ...
Support Center